December 18 Nyrada Update  
 
    Noxopharm Releases Report on Key Progress of Subsidiary Nyrada  
 
    Noxopharm Subsidiary Nyrada Announces Important Drug Discovery  
 
    AFR 30 August 2018 : Advances in Biotech - Lower cholesterol treatment breakthrough  
 
    Nyrada- key progress with cholesterol-lowering drug candidate  
 
    Nyrada, Inc. Newsletter 2. April 2018  
 
    Nyrada,Inc. Newsletter 1. Jan/Feb 2018  
 
    Noxopharm Closes $4M Capital Raising for its US Subsidiary, Nyrada,Inc.  
 
    Identification of NYX-104, a promising lead candidate for the treatment of stroke and other excitotoxicity- associated disorders.  
 
    US biotech to develop Australian science